Rxcurve
HCPCS J0565 · per 10 MG

Inj, bezlotoxumab, 10 mg

This code is not in the latest file (4Q26). It was last listed in 2Q26.

Payment limit per 10 MG, by effective quarter, 1Q21 to 2Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J0565

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
2Q26 $39.825 $0.00 10 MG Inj, bezlotoxumab, 10 mg v1, posted September 15, 2026
1Q26 $39.825 $0.00 10 MG Inj, bezlotoxumab, 10 mg v1, posted September 15, 2026
4Q25 $39.825 $0.00 10 MG Inj, bezlotoxumab, 10 mg v1, posted September 8, 2026
3Q25 $39.825 −$0.044 10 MG Inj, bezlotoxumab, 10 mg v1, posted March 10, 2026
2Q25 $39.869 +$0.004 10 MG Inj, bezlotoxumab, 10 mg v1, posted March 10, 2026
1Q25 $39.865 +$0.002 10 MG Inj, bezlotoxumab, 10 mg v1, posted December 19, 2025
4Q24 $39.863 −$0.022 10 MG Inj, bezlotoxumab, 10 mg v1, posted June 11, 2025
3Q24 $39.885 +$0.013 10 MG Inj, bezlotoxumab, 10 mg v1, posted June 11, 2025
2Q24 $39.872 +$0.014 10 MG Inj, bezlotoxumab, 10 mg v1, posted March 11, 2025
1Q24 $39.858 +$0.014 10 MG Inj, bezlotoxumab, 10 mg v1, posted December 19, 2024
4Q23 $39.844 −$0.009 10 MG Inj, bezlotoxumab, 10 mg v1, posted October 10, 2024
3Q23 $39.853 −$0.008 10 MG Inj, bezlotoxumab, 10 mg v1, posted June 5, 2024
2Q23 $39.861 −$0.035 10 MG Inj, bezlotoxumab, 10 mg v1, posted February 23, 2024
1Q23 $39.896 −$0.003 10 MG Inj, bezlotoxumab, 10 mg v1, posted December 6, 2023
4Q22 $39.899 +$0.025 10 MG Inj, bezlotoxumab, 10 mg v1, posted June 22, 2023
3Q22 $39.874 +$0.003 10 MG Inj, bezlotoxumab, 10 mg v1, posted June 9, 2023
2Q22 $39.871 +$0.085 10 MG Inj, bezlotoxumab, 10 mg v1, posted December 14, 2022
1Q22 $39.786 +$0.021 10 MG Inj, bezlotoxumab, 10 mg v1, posted June 8, 2022
4Q21 $39.765 +$0.012 10 MG Inj, bezlotoxumab, 10 mg v1, posted June 2, 2022
3Q21 $39.753 +$0.094 10 MG Inj, bezlotoxumab, 10 mg v1, posted June 2, 2022
2Q21 $39.659 −$0.007 10 MG Inj, bezlotoxumab, 10 mg v1, posted March 1, 2022
1Q21 $39.666 – 10 MG Inj, bezlotoxumab, 10 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files